| Literature DB >> 20088374 |
Abstract
Up-to now three variants of antisense technologies are known, namely antisense oligonucleotides, RNA interference, and ribozymes. In spite of different mechanisms of action, all of them are united by the common principle: an antisense preparation works after binding with RNA-target by forming a duplex. Today all three variants are intensively used in vivo. Present posture of affairs in use of antisense technologies for treating various diseases is considered in the review.Mesh:
Substances:
Year: 2009 PMID: 20088374
Source DB: PubMed Journal: Mol Biol (Mosk) ISSN: 0026-8984